By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Royalty Pharma plc

Royalty Pharma plc (RPRX)

NASDAQ Currency in USD
$472.00
+$6.03
+1.30%
Last Update: 18 Jul 2026, 14:21
$203.85bn
Market Cap
266.67
P/E Ratio (TTM)
0.20%
Forward Dividend Yield
$313.25-$577.58
52 Week Range

RPRX Stock Price Chart

Explore Royalty Pharma plc interactive price chart. Choose custom timeframes to analyze RPRX price movements and trends.

RPRX Company Profile

Discover essential business fundamentals and corporate details for Royalty Pharma plc (RPRX) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Pharmaceuticals

IPO Date

16 Jun 2020

Employees

100.00

CEO

Pablo Legorreta

Description

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

RPRX Financial Timeline

Browse a chronological timeline of Royalty Pharma plc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 5 Aug 2026

EPS estimate is $1.27, while revenue estimate is $758.88m.

Dividend declared on 15 May 2026

A dividend of $0.24 per share was announced, adjusted to $0.24. The dividend was paid on 10 Jun 2026.

Earnings released on 6 May 2026

EPS came in at $1.30 surpassing the estimated $1.21 by +7.44%, while revenue for the quarter reached $925.00m , beating expectations by +4.91%.

Dividend declared on 20 Feb 2026

A dividend of $0.24 per share was announced, adjusted to $0.24. The dividend was paid on 10 Mar 2026.

Earnings released on 11 Feb 2026

EPS came in at $1.46 surpassing the estimated $1.29 by +13.18%, while revenue for the quarter reached $874.00m , beating expectations by +8.31%.

Dividend declared on 14 Nov 2025

A dividend of $0.22 per share was announced, adjusted to $0.22. The dividend was paid on 10 Dec 2025.

Earnings released on 5 Nov 2025

EPS came in at $1.17 surpassing the estimated $0.99 by +17.71%, while revenue for the quarter reached $609.29m , missing expectations by -15.07%.

Dividend declared on 15 Aug 2025

A dividend of $0.22 per share was announced, adjusted to $0.22. The dividend was paid on 10 Sept 2025.

Earnings released on 6 Aug 2025

EPS came in at $1.14 surpassing the estimated $1.03 by +10.68%, while revenue for the quarter reached $578.67m , missing expectations by -14.02%.

Dividend declared on 16 May 2025

A dividend of $0.22 per share was announced, adjusted to $0.22. The dividend was paid on 10 Jun 2025.

Earnings released on 8 May 2025

EPS came in at $1.06 surpassing the estimated $0.95 by +11.23%, while revenue for the quarter reached $568.25m , missing expectations by -19.44%.

Dividend declared on 21 Feb 2025

A dividend of $0.22 per share was announced, adjusted to $0.22. The dividend was paid on 10 Mar 2025.

Earnings released on 11 Feb 2025

EPS came in at $1.15 surpassing the estimated $0.99 by +16.16%, while revenue for the quarter reached $594.00m , missing expectations by -13.55%.

Dividend declared on 15 Nov 2024

A dividend of $0.21 per share was announced, adjusted to $0.21. The dividend was paid on 10 Dec 2024.

Earnings released on 6 Nov 2024

EPS came in at $1.04 surpassing the estimated $0.93 by +12.07%, while revenue for the quarter reached $564.69m , missing expectations by -18.97%.

Dividend declared on 16 Aug 2024

A dividend of $0.21 per share was announced, adjusted to $0.21. The dividend was paid on 13 Sept 2024.

Earnings released on 8 Aug 2024

EPS came in at $0.96 falling short of the estimated $0.97 by -0.52%, while revenue for the quarter reached $537.27m , missing expectations by -14.37%.

Dividend declared on 16 May 2024

A dividend of $0.21 per share was announced, adjusted to $0.21. The dividend was paid on 14 Jun 2024.

Earnings released on 9 May 2024

EPS came in at $0.98 falling short of the estimated $0.99 by -0.71%, while revenue for the quarter reached $567.98m , missing expectations by -14.66%.

Earnings released on 15 Feb 2024

EPS came in at $1.15 surpassing the estimated $1.01 by +13.86%, while revenue for the quarter reached $596.00m , missing expectations by -11.53%.

Dividend declared on 15 Feb 2024

A dividend of $0.21 per share was announced, adjusted to $0.21. The dividend was paid on 15 Mar 2024.

Dividend declared on 16 Nov 2023

A dividend of $0.20 per share was announced, adjusted to $0.20. The dividend was paid on 15 Dec 2023.

Earnings released on 8 Nov 2023

EPS came in at $0.79 falling short of the estimated $0.81 by -2.47%, while revenue for the quarter reached $536.31m , missing expectations by -12.70%.

Dividend declared on 17 Aug 2023

A dividend of $0.20 per share was announced, adjusted to $0.20. The dividend was paid on 15 Sept 2023.

Earnings released on 8 Aug 2023

EPS came in at $0.85 surpassing the estimated $0.83 by +2.41%, while revenue for the quarter reached $538.20m , beating expectations by +0.30%.

Dividend declared on 18 May 2023

A dividend of $0.20 per share was announced, adjusted to $0.20. The dividend was paid on 15 Jun 2023.

Earnings released on 9 May 2023

EPS came in at $1.60 surpassing the estimated $1.32 by +21.21%, while revenue for the quarter reached $683.97m , missing expectations by -19.81%.

Earnings released on 15 Feb 2023

EPS came in at $1.56 matching the estimated $1.56, while revenue for the quarter reached $565.75m , missing expectations by -46.83%.

Dividend declared on 15 Feb 2023

A dividend of $0.20 per share was announced, adjusted to $0.20. The dividend was paid on 15 Mar 2023.

Dividend declared on 17 Nov 2022

A dividend of $0.19 per share was announced, adjusted to $0.19. The dividend was paid on 15 Dec 2022.

Earnings released on 8 Nov 2022

EPS came in at $0.73 surpassing the estimated $0.71 by +2.82%, while revenue for the quarter reached $573.46m , missing expectations by -2.19%.

Dividend declared on 18 Aug 2022

A dividend of $0.19 per share was announced, adjusted to $0.19. The dividend was paid on 15 Sept 2022.

Earnings released on 4 Aug 2022

EPS came in at $0.79 surpassing the estimated $0.78 by +1.28%, while revenue for the quarter reached $535.96m , beating expectations by +1.44%.

Dividend declared on 19 May 2022

A dividend of $0.19 per share was announced, adjusted to $0.19. The dividend was paid on 15 Jun 2022.

Earnings released on 5 May 2022

EPS came in at $0.61 falling short of the estimated $0.72 by -15.28%, while revenue for the quarter reached $562.05m , missing expectations by -5.86%.

Dividend declared on 17 Feb 2022

A dividend of $0.19 per share was announced, adjusted to $0.19. The dividend was paid on 15 Mar 2022.

Earnings released on 15 Feb 2022

EPS came in at $0.80 surpassing the estimated $0.79 by +1.27%, while revenue for the quarter reached $575.70m , beating expectations by +4.28%.

Dividend declared on 18 Nov 2021

A dividend of $0.17 per share was announced, adjusted to $0.17. The dividend was paid on 15 Dec 2021.

Earnings released on 10 Nov 2021

EPS came in at $0.73 surpassing the estimated $0.69 by +5.80%, while revenue for the quarter reached $585.77m , beating expectations by +6.15%.

Dividend declared on 19 Aug 2021

A dividend of $0.17 per share was announced, adjusted to $0.17. The dividend was paid on 15 Sept 2021.

Earnings released on 11 Aug 2021

EPS came in at $0.71 surpassing the estimated $0.70 by +1.43%, while revenue for the quarter reached $554.96m , meeting expectations.

RPRX Stock Performance

Access detailed RPRX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run